Anzeige
Mehr »
Login
Sonntag, 18.04.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
Hohe Umsätze deuten nächste Kurs-Explosion an!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
63 Leser
Artikel bewerten:
(0)

ArroGen Previews New Fingerprint Molecular Identification Technology

-- New Forensic Solution Can Reveal Gender, Nicotine, Drug, Explosives Status from a Fingerprint

GREENVILLE, North Carolina, Aug. 3, 2015 /PRNewswire/ --ArroGen Group, an integrated advanced forensic solutions company based in the United States and with operations in Oxfordshire and Newcastle, England, is unveiling its new Fingerprint Molecular Identification' (FMID) technology Aug. 2-8 at the International Association for Identification's educational conference in Sacramento, California. FMID, a new category in forensic science, will enable law enforcement agents, district attorneys and government agencies to build a molecular profile of criminal suspects.

By analyzing chemical residues on fingerprints taken from a suspect or from latent prints left at crime scenes, FMID can reveal a suspect's gender, use of tobacco, medicines and illicit drugs, and exposure to explosives.

"FMID will give investigators, prosecutors and government agencies a powerful new tool for human identification," said ArroGen CEO Michael Heffernan. "This unprecedented technology will empower their investigations and intelligence-gathering with indisputable scientific evidence, saving time and money."

ArroGen's patented process uses surface-engineered, silica-based SupraNano' powders to capture chemical residues on fingerprints and mass spectrometry to analyze the residues.

FMID can detect gender biomarkers, nicotine use and chemicals used in improvised explosives. It can also detect illicit drugs such as cocaine, heroin, methamphetamines, temazepam, marijuana and ecstasy, and legitimate medicines.

FMID for nicotine and drug use will be available in the fourth quarter of 2015, and applications for gender and explosives will be available in the first quarter of 2016.

ArroGen will display the FMID process and demonstrate its FMID kits at booth 238 in the Sacramento Convention Center.

About ArroGen Group

ArroGen LLC, headquartered in Greenville, N.C., is a private company that provides advanced forensic solutions and consulting services to help law enforcement, attorneys, forensic laboratories, and state and federal government agencies fight crime and terrorism.

The company provides fast, accurate biological screening and DNA analysis at its laboratory, accredited by ISO/IEC 17025, and is distinguished by its new human-identification technologies:

  • Fingerprint Molecular Identification' (FMID), which can analyze residues from latent fingerprints to determine a suspect's gender, nicotine status and exposure to explosives or drugs
  • QSNP Forensic Informatics', which can determine the individual DNA profiles of up to five contributors to mixed DNA samples
  • SupraNano' fingerprint powders, which produce images with higher contrast, better clarity and less background staining than traditional powders
  • SupraNano' suspensions, which allow development of latent fingerprints found on wet surfaces.
Kostenloser Wertpapierhandel auf Smartbroker.de
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.